Registration for EHDEN's Symposium in Barcelona on 10 October 2024 is now open! Keynote speakers from the European Medicines Agency, Innovative Health Initiative (IHI)and much more. Check out the agenda and register here: https://bit.ly/4ftEX3W
IMI_EHDEN
Research Services
European Health Data & Evidence Network (EHDEN received funding from the IMI 2 JU under grant agreement No 806968)
About us
EHDEN (European Health Data & Evidence Network) was created as a public-private partnership under the framework of the IMI. EHDEN aspires to be a trusted observational research ecosystem that enables better health decisions, outcomes and care for patients across Europe. To achieve this, EHDEN has created a large-scale, federated network of harmonised data sources standardised to the OMOP common data model. Website: www.ehden.eu Twitter: @IMI_EHDEN Github: www.github.com/EHDEN
- Website
-
http://www.ehden.eu
External link for IMI_EHDEN
- Industry
- Research Services
- Company size
- 51-200 employees
- Headquarters
- Brussels
- Type
- Nonprofit
- Founded
- 2018
Locations
-
Primary
Brussels, BE
Employees at IMI_EHDEN
Updates
-
July blog now live! EHDEN Academy Lead, Scientific Researcher, Henrik John provides an update on how the Academy is evolving its curriculum with more emphasis upon #vocationalexcellence. Read the full blog here: https://bit.ly/3zGzl65
BLOG - Transforming Healthcare Through Education: What’s Next for the EHDEN Academy? – ehden.eu
https://www.ehden.eu
-
"Safeguarding Against Critical Medicines' Shortage" study update: Results (now in preprint) from incidence and prevalence of medicines with suggested drug shortages and their alternatives were discussed by 70 participants from 20 countries during our first webinar in June. Key take-aways: great learnings of differences between countries, markets, and healthcare settings. The September 5 webinar will address the characteristics of users of medicines with suggested shortages and their alternatives. More about this important from the original post: https://bit.ly/3HA1goV
Safeguarding against critical medicines’ shortage – ehden.eu
https://www.ehden.eu
-
Indeed, excellent summary, Liesbet M. PEETERS - you and the Belgian team are pace-setters!
Data scientist 🦄 - Entrepreneur 🐸 - Idealist 🦋 Passionate about using my talents to make the world a better place
🚢 Today, I had the pleasure of attending the Fifth European OHDSI Symposium on the Steam Ship Rotterdam in the vibrant city of Rotterdam, Netherlands. 🌍 The event themed "Scaling up reliable evidence across Europe" gathered 360 participants from 37 countries, representing academia, industry, and regulators. 📝 I’m excited to share my key takeaways and reflections from this inspiring event in my latest article. From groundbreaking research findings to fostering international collaborations, the symposium provided a wealth of knowledge and a renewed sense of purpose in our work. 👩💻 Special shout out to Tina Parciak, PhD student in my research group, who presented her work on transforming Multiple Sclerosis Real-World Data to the OMOP CDM. Her dedication and expertise are truly impressive. 📈 Curious about the European initiatives using the OMOP CDM? Or the future steps for OHDSI Belgium? Find out more in the article. Let’s continue to push the boundaries of health data science together! OHDSI (Observational Health Data Sciences & Informatics) OHDSI Belgium IMI_EHDEN #DARWINEU #HealthDataScience #RealWorldData #OMOPCDM #ClinicalResearch #HealthcareInnovation #DataSavesLives
Key takeaways from the 5th European OHDSI Symposium: “Scaling Up Reliable Evidence Across Europe”
Liesbet M. PEETERS on LinkedIn
-
Day 3 of the OHDSI Europe Symposium wrapped up on the majestic SS Rotterdam. Large-scale #evidencegeneration was the focus of two important EHDEN studies: Predicting long-term #cancer for Health Technology Assessment - A Multinational Cohort Study Across Europe, presented by Jeremy D., NICE, UK, and Trends Over Time in Medicines with Suggested Shortages in Europe, presented by Marta Pineda Moncusí, Oxford University, UK.
-
-
More OHDSI Europe Symposium Day 2 highlights. EHDEN co-lead, Peter R. hosted an EHDEN Data Parter/SME luncheon to give a recap of the group's latest achievements and look ahead to the EHDEN Foundation. EHDEN colleagues Henrik John and Renske Los working from the Erasmus Medical Center in Rotterdam ran an EHDEN Academy hack-a-thon to explore ways to expand the curriculum and discuss other related aspects.
-
-
Day 2 of the OHDSI Europe Symposium in Rotterdam kicked off with a workgroup meeting led by Christian Reich, Patrick Ryan and others. This session was all about OHDSI Standardized Vocabularies with a focus on phenotyping.
-
-
Two enthusiastic workgroups wrapped up Day 1 at the #OHDSI Europe Symposium in Rotterdam: Asieh Golozar, VP, Global Head of Data Science at Odysseus Data Services led a session that reviewed and redefined oncology use cases. PhD Student, Clinical NLP, Erasmus Medical Center, Tom Seinen's group discussed the use of natural language processing in the #OMOPCDM.
-